A Courties, I Kouki, N Soliman, S Mathieu… - Osteoarthritis and …, 2024 - Elsevier
Abstract This" Year in Review" presents a curated selection of research themes and individual studies within the clinical osteoarthritis (OA) field, focusing on epidemiology and …
F Migliorini, M Pilone, J Ascani, L Schäfer… - British Medical …, 2024 - researchgate.net
Introduction: Knee osteoarthritis (OA) is a common degenerative joint condition and a major cause of disability in the general population. Source of data: Recent published literature …
H Huang, JR Bach, HS Sharma, L Chen, P Wu… - Journal of …, 2024 - Elsevier
Remarkable advancements have been made in understanding the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurological disease; in our depth of …
Purpose Injectable biologics have not only been described and developed to treat dermal wounds, cardiovascular disease, and cancer, but have also been reported to treat chronic …
T O'Connor, S Chatterjee, J Lam… - International Journal of …, 2024 - Elsevier
Process models are a growing tool for pharmaceutical manufacturing process design and control. The Industry 4.0 paradigm promises to increase the amount of data available to …
T Winkler, S Geissler, T Maleitzke… - EFORT Open …, 2024 - eor.bioscientifica.com
Advanced therapies are expected to play a crucial role in supporting repair after injury, halting the degeneration of musculoskeletal tissue to enable and promote physical activity …
Z Zhao, P Wang, Z Li, X Wei, S Li, X Lu, S Dai… - Journal of …, 2024 - Springer
Osteoarthritis (OA) is the most common disease in aging joints and has characteristics of cartilage destruction and inflammation. It is currently considered a metabolic disease, and …
Background The comorbidity of chronic pancreatitis (CP) in patients with osteoarthritis (OA) is insufficiently studied, and the reciprocal impact of these conditions remains poorly …
YM Pers, R Soler-Rich, G Vadalà, R Ferreira… - Annals of the Rheumatic …, 2024 - Elsevier
Objectives To assess the efficacy of a single intradiscal injection of allogeneic bone marrow mesenchymal stromal cells (BM-MSCs) versus a sham placebo in patients with chronic low …